Doping and Anti-Doping Basics

Under the Seventh Schedule of the Constitution of India, “Sports” is classified under Entry 33 of the State List (List II). However, compliance with international treaties, anti-doping regulations, and global sports conventions falls under the exclusive executive domain of the Union Government via the Ministry of Youth Affairs and Sports (MYAS). The National Anti-Doping Agency (NADA) was established as an autonomous body under the Societies Registration Act, 1860, to implement anti-doping programs in India. To strengthen this framework, the Parliament enacted the National Anti-Doping Act, 2022, which provides a statutory basis for NADA’s operations, gives the agency investigative powers, and establishes the National Anti-Doping Disciplinary Panel.

Global Oversight and the UNESCO Convention

At the international level, anti-doping governance is led by the World Anti-Doping Agency (WADA), an independent international foundation established in 1999 under the Declaration of Lausanne. WADA manages the World Anti-Doping Code (WADC), which standardizes anti-doping regulations across all sports and countries. The legal authority for this global code is reinforced by the UNESCO International Convention against Doping in Sport (2005). This treaty obligates member nations, including India, to align their domestic public policies with WADA regulations, ensuring international legal cooperation and uniform testing standards.

Taxonomic Classification of Prohibited Substances and Methods

WADA publishes an updated Prohibited List every calendar year, classifying substances and methods based on their pharmacological properties, performance-enhancing capabilities, and health risks.

Substances Prohibited at All Times (In- and Out-of-Competition)

• S0: Non-Approved Substances: Any pharmacological substance not addressed by other sections of the list and not approved by any governmental regulatory health authority for human therapeutic use (e.g., experimental drugs or designer substances).
• S1: Anabolic Agents: Exogenous and endogenous anabolic androgenic steroids (AAS) that mimic natural testosterone, stimulating muscle protein synthesis and acceleration of tissue recovery. Examples include Metandienone, Stanozolol, and Nandrolone.
• S2: Peptide Hormones, Growth Factors, and Related Substances: Hormones that stimulate red blood cell production or muscle growth. Examples include Erythropoietin (EPO), Human Growth Hormone (hGH), and Gonadotropins.
• S3: Beta-2 Agonists: Bronchodilators commonly prescribed for asthma that can improve respiratory efficiency and provide anabolic effects at high doses. Examples include Salbutamol (above specific dosage limits), Formoterol, and Terbutaline.
• S4: Hormone and Metabolic Modulators: Substances that alter hormonal axes or metabolic pathways, often used to suppress the side effects of steroids or modify estrogen-testosterone ratios. Examples include Tamoxifen, Clomifene, and Insulin.
• S5: Diuretics and Masking Agents: Compounds that increase urine output and clear water from the body. They are used to dilute urine to lower drug concentrations or to rapidly drop weight in weight-category sports. Examples include Furosemide, Hydrochlorothiazide, and Spironolactone.

Substances Prohibited In-Competition Only

• S6: Stimulants: Chemicals that increase central nervous system activity, heart rate, and alertness. Examples include Amphetamine, Cocaine, Ephedrine, and Modafinil.
• S7: Narcotics: Potent analgesics that suppress severe physical pain, allowing athletes to compete through structural tissue injuries. Examples include Morphine, Oxycodone, and Fentanyl.
• S8: Cannabinoids: Natural or synthetic tetrahydrocannabinol (THC) and cannabis derivatives, excluding pure Cannabidiol (CBD).
• S9: Glucocorticoids: Anti-inflammatory corticosteroids that can alter glucose metabolism and suppress pain perceptions when administered via systemic routes.

Prohibited Methods at All Times

• M1: Manipulation of Blood and Blood Components: Processes that artificially enhance oxygen transport to muscles. This includes autologous blood transfusions (using the athlete’s own stored blood) or homologous blood transfusions (using compatible donor blood), as well as artificially introducing hemoglobin products.
• M2: Chemical and Physical Manipulation: Tampering, or attempting to tamper, with samples to alter their integrity during collection. This includes urine substitution, chemical alteration, or intravenous infusions exceeding 100 mL per 12-hour period (unless clinically indicated).
• M3: Gene and Cell Doping: The illegal use of nucleic acids, genetically modified cells, or gene-editing technologies (like CRISPR-Cas9) to alter gene expression profiles for athletic advantages, such as increasing muscle growth or red blood cell count.

Scientific Mechanisms of Testing and Longitudinal Monitoring

Anti-doping organizations use two main testing approaches: direct substance detection and longitudinal biological monitoring.

Sample Collection and Laboratory Analysis

Testing is divided into In-Competition (ICT) and Out-of-Competition (OOCT) testing, conducted without advance notice. Doping Control Officers (DCOs) collect blood and urine samples, splitting them immediately into an ‘A’ sample (used for initial analytical screening) and a ‘B’ sample (stored securely for confirmatory verification if the ‘A’ sample returns an adverse finding). Analysis must be conducted exclusively in WADA-accredited laboratories, such as the National Dope Testing Laboratory (NDTL) in New Delhi. These labs use advanced technology, including Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), to isolate and identify minute quantities of prohibited compounds.

The Athlete Biological Passport (ABP)

The Athlete Biological Passport (ABP) monitors selected biological variables over time rather than looking for a specific substance. This longitudinal approach detects the physiological footprint of doping and is divided into two operational modules:

The Hematological Module

• Primary Biomarkers Tracked: Hemoglobin (HGB) concentration, Reticulocyte (RET%) percentage, and the calculated Off-Score index.
• Doping Detection Focus: Identifies artificial blood manipulation, such as blood transfusions, EPO injections, or hypoxic chamber abuse, by flagging abnormal variations in red blood cell parameters.

The Steroidal Module

• Primary Biomarkers Tracked: Urinary concentrations of Testosterone (T), Epitestosterone (E), and the corresponding Testosterone/Epitestosterone (T/E) ratio.
• Doping Detection Focus: Detects the administration of endogenous anabolic androgenic steroids. A standard human T/E ratio is typically 1:1; a ratio exceeding 4:1 triggers immediate isotope ratio mass spectrometry (IRMS) testing to differentiate natural hormones from synthetic options.

Key Anti-Doping Regulations and Analytical Metrics

High-Yield Technical Concepts and Examination Trivia

The Science of Detection: Isotope Ratio Mass Spectrometry (IRMS)

When an athlete’s steroidal profile show a Testosterone-to-Epitestosterone (T/E) ratio greater than 4:1, WADA-accredited laboratories use Isotope Ratio Mass Spectrometry (IRMS) to confirm the finding. This technique distinguishes natural testosterone produced by the body from synthetic testosterone derived from plant sterols (such as wild yam or soy). Synthetic testosterone contains a lower percentage of the stable carbon-13 isotope (¹³C) relative to carbon-12 (¹²C) compared to natural human testosterone. By measuring this precise carbon isotope ratio (¹³C/¹²C), scientists can definitively prove the presence of synthetic hormones, providing conclusive evidence for an anti-doping rule violation even if the total hormone concentration falls within normal human ranges.

Meldonium and the Shift in Metabolic Manipulation Tracking

Meldonium (Mildronate) is an entry on the WADA Prohibited List that demonstrates how anti-doping regulations evolve alongside sports science. Developed in Latvia as an anti-ischemic medication, Meldonium shifts cellular energy metabolism away from fatty acid oxidation toward glycolysis under hypoxic conditions. This action lowers the oxygen cost of physical exertion, protecting cardiac tissues and accelerating recovery times during intense cardiovascular stress. WADA placed Meldonium under monitoring before officially banning it in 2016 under the S4 class (Hormone and Metabolic Modulators). This decision followed a significant spike in usage among elite endurance athletes, showing how quickly the list updates to address new patterns of metabolic optimization.